PetMed Express Inc (PETS)

Name: PetMed Express Inc (PETS) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name PETMED EXPRESS INC · CIK 0001040130 · Nasdaq · Retail-Drug Stores and Proprietary Stores

Sector Retail Trade
Incorporated FL
Fiscal year ends Mar 31

For the year ended 2026-03-31, PetMed Express Inc reported revenue of $179.02M. Revenue fell 21.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $168.86M.

Key ratios (year ended 2026-03-31)

28.1%

Gross margin

-32.8%

Operating margin

-32.0%

Net margin

-197.9%

Return on year-end equity

-21.1%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-29

Headquarters locality: Pompano Beach · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31
Revenue	$168.86M	$179.02M	$226.97M	$274.10M	$247.57M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	$157.84M	$189.33M	$171.07M	$195.34M	$219.27M	$202.88M	$188.10M	$175.99M	$169.86M
Gross Profit	$47.15M	$50.22M	$69.14M	$84.77M	$76.50M	$76.94M	$84.32M	$81.25M	$95.31M	$97.81M	$79.31M
Operating Income	-$30.77M	-$58.67M	-$1.53M	-$8.16M	$6.05M	$24.29M	$30.53M	$30.98M	$46.17M	$52.14M	$37.48M
Depreciation & Amortization	$9.25M	$9.39M	$7.04M	$7.06M	$3.55M	$2.74M	n/a	n/a	n/a	n/a	n/a
EBITDA	-$21.52M	-$49.29M	$5.51M	-$1.11M	$9.60M	$27.03M	n/a	n/a	n/a	n/a	n/a
Net Income	-$29.28M	-$57.29M	-$6.27M	-$7.46M	$5.14M	$18.72M	$23.92M	$25.85M	$37.74M	$37.28M	$23.82M
EPS (Diluted)	n/a	-$2.74	-$0.30	-$0.37	$0.25	$0.92	$1.19	$1.29	$1.84	$1.82	$1.17
Total Assets	$63.76M	$81.19M	$148.70M	$169.88M	$167.48M	$179.70M	$187.50M	$155.32M	$154.43M	$134.84M	$112.81M
Total Liabilities	$40.77M	$52.25M	$63.57M	$73.15M	$57.51M	$56.25M	$46.22M	$25.31M	$19.75M	$19.11M	$19.44M
Shareholders' Equity	$22.99M	$28.94M	$85.13M	$96.73M	$109.97M	$123.45M	$124.93M	$130.01M	$134.68M	$115.73M	$93.37M
Cash & Equivalents	$13.08M	$21.41M	$54.72M	$55.30M	$104.09M	$111.08M	$118.72M	$103.76M	$100.53M	$77.94M	$58.73M
Operating Cash Flow	-$23.81M	-$28.39M	$4.72M	$4.32M	$27.80M	$18.50M	$40.08M	$38.84M	$45.14M	$37.38M	$47.20M
Capital Expenditures	$3.96M	$4.62M	$5.11M	$4.51M	$5.26M	$1.75M	$2.43M	$2.31M	$620.0K	$703.0K	$10.60M
Free Cash Flow	-$27.77M	-$33.01M	-$395.0K	-$194.0K	$22.54M	$16.75M	$37.64M	$36.53M	$44.52M	$36.68M	$36.60M
Share Repurchases	n/a	n/a	n/a	n/a	n/a	$0	$0	$11.50M	$0	n/a	n/a
Dividends Paid	$20.0K	$21.0K	$181.0K	$12.44M	$24.54M	$24.38M	$22.69M	$21.80M	$21.93M	$17.47M	$15.51M
Shares Outstanding	21.68M	21.39M	20.66M	21.15M	21.08M	20.98M	20.27M	20.17M	20.67M	20.60M	20.53M
Dividends Per Share	n/a	$0.00	$0.00	$0.60	$1.20	$1.20	$1.12	$1.08	$1.06	$0.85	$0.76
Weighted Average Diluted Shares	n/a	20.92M	20.60M	20.40M	20.34M	20.36M	20.12M	20.05M	20.49M	20.43M	20.38M
EPS (Basic)	n/a	-$2.74	-$0.30	-$0.37	$0.25	$0.93	$1.19	$1.29	$1.84	$1.83	$1.18

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView